TAYTULLA
Peaknorethindrone acetate and ethinyl estradiol, and ferrous fumarate
NDAORALCAPSULE
Approved
Apr 2013
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
3/8 — Basic
TAYTULLA (norethindrone acetate and ethinyl estradiol, and ferrous fumarate) by Ichnos Glenmark Innovation is ovulation. First approved in 2013.
Drug data last refreshed 6h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TAYTULLA is an oral contraceptive capsule combining norethindrone acetate, ethinyl estradiol, and ferrous fumarate (iron supplement). It prevents ovulation through hormonal suppression and provides iron supplementation to offset menstrual blood loss. This combination formulation targets women seeking pregnancy prevention with integrated iron replacement.
$0.03BPart D
PeakStable
Mature contraceptive franchise in stable lifecycle with modest Part D utilization suggests a stable but non-growth commercial opportunity.
Mechanism of Action
ovulation.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on TAYTULLA offers stable, established-market experience in a mature contraceptive franchise with limited growth opportunities. The role emphasizes defending market share, managing payer relationships, and optimizing sales efficiency rather than driving innovation or clinical advancement.
Brand ManagerField Sales Representative
Worked on TAYTULLA at Ichnos Glenmark Innovation? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.